Cargando…

New Boron Containing Acridines: Synthesis and Preliminary Biological Study

The synthesis of the first conjugates of acridine with cobalt bis(dicarbollide) are reported. A novel 9-azido derivative of acridine was prepared through the reaction of 9-methoxyacridine with N(3)CH(2)CH(2)NH(2), and its solid-state molecular structure was determined via single-crystal X-ray diffra...

Descripción completa

Detalles Bibliográficos
Autores principales: Druzina, Anna A., Dudarova, Nadezhda V., Ananyev, Ivan V., Antonets, Anastasia A., Kaluzhny, Dmitry N., Nazarov, Alexey A., Sivaev, Igor B., Bregadze, Vladimir I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650824/
https://www.ncbi.nlm.nih.gov/pubmed/37764412
http://dx.doi.org/10.3390/molecules28186636
Descripción
Sumario:The synthesis of the first conjugates of acridine with cobalt bis(dicarbollide) are reported. A novel 9-azido derivative of acridine was prepared through the reaction of 9-methoxyacridine with N(3)CH(2)CH(2)NH(2), and its solid-state molecular structure was determined via single-crystal X-ray diffraction. The azidoacridine was used in a copper (I)-catalyzed azide-alkyne cycloaddition reaction with cobalt bis(dicarbollide)-based terminal alkynes to give the target 1,2,3-triazoles. DNA interaction studies via absorbance spectroscopy showed the weak binding of the obtained conjugates with DNA. The antiproliferative activity (IC(50)) of the boronated conjugates against a series of human cell lines was evaluated through an MTT assay. The results suggested that acridine derivatives of cobalt bis(dicarbollide) might serve as a novel scaffold for the future development of new agents for boron neutron capture therapy (BNCT).